The antiepileptic drugs, namely, valproate and levetiracetam can lead to a decrease in serum CCL2 levels in children with epilepsy, suggesting that CCL2 may be a potential target for epilepsy drug therapy.53 Here, CCL2 is linked to epilepsy.